Please use this identifier to cite or link to this item:
|Title:||Cytotoxin with a Subtilase Domain|
|Assignee:||ARI Pty Ltd|
|Contributor:||A.P.T. Patent and Trade Mark Attorneys|
|Inventors A. W. Paton, J. C. Paton; Assigned to Adelaide Research and Innovation Pty Ltd; A.P.T. Patent and Trade Mark Attorneys agents to inventors.|
|Abstract:||A member of a new class of bacterial toxin has been isolated and characterised. The bacterial toxin is of the AB₅ type and is characterised in that it has a subtilase domain. It is cytotoxic to Vero cells, and toxicity in vivo in mice occurs in a number of different sites. Mutation of the serine active residue results in greater than 99% reduction in activity. The protein has been purified and antibodies have been prepared for both the A subunit and B subunits, and ELISA detection methods have been developed. The nucleic acid sequence has been determined and primers specific for the toxin have been used for a preliminary screen of a range of patient samples to ascertain the extent to which the toxin is present.|
|Keywords:||AU 2004/201978 B2|
|Description:||PATENT: A. W. Paton, J. C. Paton (Assignee Adelaide Research and Innovation Pty Ltd). AU 2004/201978 A1 filed May 12, 2004; published Jul 7, 2005; Standard Patent Sealed Jun 24, 2010; expiry date May 12, 2024.|
|Appears in Collections:||Molecular and Biomedical Science publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.